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geographically distinct, Caucasian population, the possibility
of population stratification in the Elmore et al study and low
statistical significance in the context of genome wide multiple
testing suggest that this region should not be considered as an AAA
locus at this time.
Gregory T. Jones, PhD
André M. van Rij, MBChB, MD, FRACS
Department of Surgery




1. Jones GT, Thompson AR, van Bockxmeer FM, Hafez H, Cooper JA,
Golledge J, et al. Angiotensin II type 1 receptor 1166C polymorphism is
associated with abdominal aortic aneurysm in three independent cohorts.
Arterioscler Thromb Vasc Biol 2008;28:764-70.
doi:10.1016/j.jvs.2009.07.098
Reply
We thank the investigators for their interest in our paper,1 and
would like to make several points regarding their observations.
First, their sample size is underpowered for a replication study of
the reported association. For an association with an odds ratio of
1.3 and minor allele frequency of 0.4, the statistical power is 0.45
(based on an allelic genetic model) at   0.05.2 Therefore, the
failure to replicate the association is not conclusive. Second, the
investigators do report a statistically significant association with
single nucleotide polymorphisms (SNP) in intron 2 of the CNTN3
gene. This supports our working hypothesis that a functional
variant in this region influences the phenotype. The differences in
specific genetic variants that are statistically associated with the
disease (and presumably a common functional genetic variant)
could reflect different haplotype structures in the study popula-
tions. Third, a difference in haplotype structure is further sug-
gested by our failure to replicate in our study population their
previously reported association of SNP rs5186 in the AGTR1 gene
with abdominal aortic aneurysm (AAA)3 (Table). Assuming the
reported odds ratio of 1.6,3 our sample size has 0.98 power to
detect an association (allelic genetic model,   0.05). Finally,
these considerations highlight some of the challenges of discover-
Table. SNP associations with AAA
Chr SNP marker Position AAA MAF Control MAF 2
3 RS7635818 74866166 0.4416 0.4437 0.01
3 RS9876789 74628570 0.0565 0.0824 5.80
3 RS6549604 74628467 0.0671 0.0915 4.54
3 RS4076052 74623970 0.0212 0.0353 4.04
AAA, Abdominal aortic aneurysm; Chr, chromosome; MAF, minor allele f
A total of 567 AAA cases and 552 elderly vascular disease (including AAA)
Table. SNP rs5186 Association with AAA*





0.32 0.29 0.20 1.1 0.95-1.3
AAA, Abdominal aortic aneurysm; MAF, minor allele frequency; SNP,
single nucleotide polymorphism.
*704 AAA cases and 800 controls from the Geisinger Clinic population.ing and validating the association of common genetic variants with
complex diseases. We are open to working collaboratively with
other investigators to overcome these challenges in addressing
important research questions.
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Regarding “Incorporating outpatient venous
procedures into a vascular surgery practice”
The American Board of Phlebology (ABPh) agrees with many
of the points raised in the article by Shortell and Markovic.1 There
has been tremendous interest by physicians from a variety of
specialty backgrounds as a result of major new concepts and
significant innovations in the diagnosis and treatment of common
vein disorders. Duplex imaging has been critical to many of these
advances. Many vein procedures can now be done in an office-
based setting by using percutaneous or simple surgical procedures
and thus are being performed by primary care physicians, gynecol-
ogists, general surgeons, interventional radiologists, dermatolo-
gists, and physicians from other specialty backgrounds. Physicians
and surgeons from a variety of specialties have contributed to these
innovations.2-5
The mission of the ABPh, an independent nonprofit organi-
zation, is to improve the base of knowledge and experience of
value Odds ratio 95% Confidence interval Gene region
9187 0.9913 0.839-1.172 intergenic
01596 0.6671 0.479-0.929 CNTN3 intron 2
03301 0.7147 0.524-0.974 CNTN3 intron 2
04434 0.5926 0.354-0.992 CNTN3 intron 2
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proved educational standards.
In accordance with this mandate, the ABPh Certification
Examination was developed using the Standards for Educational
and Psychological Testing, which establishes procedures for exami-
nation development to ensure valid interpretation of score results.
Standards is published and adopted by the American Educational
Research Association, the American Psychological Association,
and the National Council on Measurement in Education.
To become board certified, a phlebologist must:
● meet professional standing requirements;
● complete the requisite training or experience qualifications;
● meet the continuing medical education requisites; and
● pass a certification examination.
The ABPh was created in response to the concerns that there
is no residency devoted to training physicians in the field of
phlebology, that the level of training in venous procedures is very
diverse across existing training programs, including vascular sur-
gery,6 and that many physicians in those specialties have had little
or no training in phlebology during their residency or fellowship
training.
The ABPh is designed to foster specialized care for patients
with venous disease by providing a certification that rigorously
evaluates whether a physician has the necessary knowledge, skills,
and abilities to provide high-quality care for venous disorders. It
should be noted that, at this time, the ABPh is the only certification
that requires its Diplomates to demonstrate both knowledge and
experience specifically in the area of venous diseases, including
venous duplex ultrasound imaging. It is important to correct one
error in the Shortell and Markovic article. The ABPh certification
process is based on American Board of Medical Specialties (ABMS)
criteria; however, the ABPh is not currently one of the 24 member
boards recognized by the ABMS.As of July 2009, the ABPh has 412 Diplomates, with specialty
backgrounds including vascular surgery, general surgery, interven-
tional radiology, family practice, internal medicine, vascular med-
icine, dermatology, plastic surgery, and gynecology. The interest
and expertise of the physician and the quality of the care given to
the patient are far more important factors than the specialty origi-
nally chosen by the practitioner.
Steven E. Zimmet, MD
President, American Board of Phlebology
Austin, Tex
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